OBJECTIVE: We have shown that acute edema induced by mesenteric venous hypertension (MV-HTN) impairs intestinal transit and reduces the standardized engineering measures of intestinal stiffness (elastic modulus) and residual stress (opening angle). We hypothesized that hypertonic saline (7.5%) would reverse these detrimental effects of acute edema. DESIGN: Laboratory study. SETTING: University laboratory. SUBJECTS: Male Sprague Dawley rats (270-330 g). INTERVENTIONS: Rats were randomized to five groups: sham, MV-HTN alone, MV-HTN with 4 mL/kg normal saline resuscitation (equal volume), MV-HTN with 33 mL/kg normal saline resuscitation (equal salt), and MV-HTN with 4 mL/kg hypertonic saline. Intestinal edema was measured by wet to dry tissue weight ratio. A duodenal catheter was placed and, 30 mins before death, fluorescein isothiocyanate Dextran was injected. At death, dye concentrations were measured to determine intestinal transit. Segments of distal ileum were hung to a fixed point in a tissue bath and to a force displacement transducer and stretched in increments of 1 mm; we recorded the new length and the corresponding force from the force displacement transducer to determine elastic modulus. Next, two transverse cuts were made yielding a 1- to 2-mm thick ring-shaped segment of tissue which was then cut radially to open the ring. Then the opening angle was measured. MEASUREMENTS AND MAIN RESULTS: MV-HTN, MV-HTN with 4 mL/kg normal saline, and MV-HTN with 33 mL/kg normal saline caused a significant increase in tissue edema and a significant decrease in intestinal transit, stiffness, and residual stress compared with sham. Hypertonic saline significantly lessened the effect of edema on intestinal transit and prevented the changes in stiffness and residual stress. CONCLUSIONS: Hypertonic saline prevented intestinal tissue edema. In addition, hypertonic saline improved intestinal transit, possibly through more efficient transmission of muscle force through stiffer intestinal tissue.
OBJECTIVE: We have shown that acute edema induced by mesenteric venous hypertension (MV-HTN) impairs intestinal transit and reduces the standardized engineering measures of intestinal stiffness (elastic modulus) and residual stress (opening angle). We hypothesized that hypertonicsaline (7.5%) would reverse these detrimental effects of acute edema. DESIGN: Laboratory study. SETTING: University laboratory. SUBJECTS: Male Sprague Dawley rats (270-330 g). INTERVENTIONS:Rats were randomized to five groups: sham, MV-HTN alone, MV-HTN with 4 mL/kg normal saline resuscitation (equal volume), MV-HTN with 33 mL/kg normal saline resuscitation (equal salt), and MV-HTN with 4 mL/kg hypertonicsaline. Intestinal edema was measured by wet to dry tissue weight ratio. A duodenal catheter was placed and, 30 mins before death, fluorescein isothiocyanate Dextran was injected. At death, dye concentrations were measured to determine intestinal transit. Segments of distal ileum were hung to a fixed point in a tissue bath and to a force displacement transducer and stretched in increments of 1 mm; we recorded the new length and the corresponding force from the force displacement transducer to determine elastic modulus. Next, two transverse cuts were made yielding a 1- to 2-mm thick ring-shaped segment of tissue which was then cut radially to open the ring. Then the opening angle was measured. MEASUREMENTS AND MAIN RESULTS: MV-HTN, MV-HTN with 4 mL/kg normal saline, and MV-HTN with 33 mL/kg normal saline caused a significant increase in tissue edema and a significant decrease in intestinal transit, stiffness, and residual stress compared with sham. Hypertonicsaline significantly lessened the effect of edema on intestinal transit and prevented the changes in stiffness and residual stress. CONCLUSIONS:Hypertonicsaline prevented intestinal tissue edema. In addition, hypertonicsaline improved intestinal transit, possibly through more efficient transmission of muscle force through stiffer intestinal tissue.
Authors: Tyler J Loftus; Philip A Efron; Trina M Bala; Martin D Rosenthal; Chasen A Croft; Michael S Walters; R Stephen Smith; Frederick A Moore; Alicia M Mohr; Scott C Brakenridge Journal: J Trauma Acute Care Surg Date: 2019-04 Impact factor: 3.313
Authors: S K Shah; S D Moore-Olufemi; K S Uray; F Jimenez; P A Walker; H Xue; R H Stewart; G A Laine; C S Cox Journal: Neurogastroenterol Motil Date: 2010-06-28 Impact factor: 3.598
Authors: Tyler J Loftus; Philip A Efron; Trina M Bala; Martin D Rosenthal; Chasen A Croft; R Stephen Smith; Frederick A Moore; Alicia M Mohr; Scott C Brakenridge Journal: J Trauma Acute Care Surg Date: 2018-02 Impact factor: 3.313
Authors: Karen S Uray; Shinil K Shah; Ravi S Radhakrishnan; Fernando Jimenez; Peter A Walker; Randolph H Stewart; Glen A Laine; Charles S Cox Journal: Surgery Date: 2011-01 Impact factor: 3.982
Authors: Shinil K Shah; Hasen Xue; Fernando Jimenez; Alexander Y Kots; Byung-Kwon Choi; Karen S Uray; Peter A Walker; Stacey D Moore-Olufemi; Natalia Velez; Randolph H Stewart; Glen A Laine; Charles S Cox Journal: J Surg Res Date: 2010-03-19 Impact factor: 2.192
Authors: Ravi S Radhakrishnan; Shinil K Shah; Samuel H Lance; Hari R Radhakrishnan; Hasen Xue; Geetha L Radhakrishnan; Uma S Ramaswamy; Peter A Walker; Karen S Uray; Glen A Laine; Randolph H Stewart; Charles S Cox Journal: Crit Care Med Date: 2009-11 Impact factor: 7.598
Authors: Shinil K Shah; Lindsey N Fogle; Kevin R Aroom; Brijesh S Gill; Stacey D Moore-Olufemi; Fernando Jimenez; Karen S Uray; Peter A Walker; Randolph H Stewart; Glen A Laine; Charles S Cox Journal: Surgery Date: 2010-01-25 Impact factor: 3.982
Authors: Ravi S Radhakrishnan; Geetha L Radhakrishnan; Hari R Radhakrishnan; Hasen Xue; Sasha D Adams; Stacey D Moore-Olufemi; Matthew T Harting; Charles S Cox; Bruce C Kone Journal: Shock Date: 2008-11 Impact factor: 3.454